CN
    News & Events

    News & Events

    Chipscreen Highlights: Stay Updated on Recent Hot Topics

    Select year

    2026 2025 2024 2023 2022 Earlier
    shown/page
    5
    5 10 15 20

    2024.06.08

    Chipscreen Biosciences' Chidamide tablets designated as a breakthrough therapy for advanced colorectal cancer
    Chipscreen Biosciences' Chidamide tablets designated as a breakthrough therapy for advanced colorectal cancer

    Full text

    2024.04.30

    National Medical Products Administration (NMPA) Approves Chipscreen Bioscience’s Chidamide (Epidaza) combined with R-CHOP for the treatment of diffuse large B-cell lymphoma
    National Medical Products Administration (NMPA) Approves Chipscreen Bioscience’s Chidamide (Epidaza) combined with R-CHOP for the treatment of diffuse large B-cell lymphoma

    Full text

    2024.04.25

    “Chinese Researchers + Innovative Drugs” Shine on the Global Stage | Chidamide Clinical Studies Selected for 2024 ASCO LBA and Multiple Presentations
    “Chinese Researchers + Innovative Drugs” Shine on the Global Stage | Chidamide Clinical Studies Selected for 2024 ASCO LBA and Multiple Presentations

    Full text

    2024.03.18

    Wang Cheng, Secretary of the Party Committee and Chairman of Sichuan Energy Investment, and his team visited Chipscreen Biosciences for inspection and survey
    Wang Cheng, Secretary of the Party Committee and Chairman of Sichuan Energy Investment, and his team visited Chipscreen Biosciences for inspection and survey

    Full text

    2024.03.18

    Positive results from Phase II clinical trial (CGZ203 study) of Chiglitazar monotherapy for non-alcoholic steatohepatitis
    Positive results from Phase II clinical trial (CGZ203 study) of Chiglitazar monotherapy for non-alcoholic steatohepatitis

    Full text
    Media contact

    Media contact

    • Media contact

      （+86）0755-36993500

    • Media contact

      pr@juliucq.com